Cancer Research UK scheme secures £280m buy-in with Standard Life

BPA deal secures the benefits of 2,800 scheme members

Holly Roach
clock • 2 min read
Cancer Research UK scheme secures £280m buy-in with Standard Life

The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.

The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...

To continue reading this article...

Join Professional Pensions

Become a Professional Pensions Lite Member today

  • Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
  • Receive important and breaking news stories via our two daily news alerts
  • Hear from industry experts and other forward-thinking leaders

Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

Join now

 

Already a Professional Pensions
member?

Login

More on Risk Reduction

Royal Horticultural Society scheme secures £22m buy-in with Royal London

Royal Horticultural Society scheme secures £22m buy-in with Royal London

Transaction secures the benefits of 230 pension scheme members

Holly Roach
clock 13 August 2026 • 2 min read
Utmost Life and Pensions appoints Aberdeen to manage CRE lending brief

Utmost Life and Pensions appoints Aberdeen to manage CRE lending brief

Deal will support insurer’s growing bulk annuity business

Jonathan Stapleton
clock 12 August 2026 • 2 min read
L&G confirms £2bn of UK PRT volumes written in H1 2026

L&G confirms £2bn of UK PRT volumes written in H1 2026

Insurer’s half-year results show institutional retirement operating profit grew to £646m

Martin Richmond
clock 05 August 2026 • 2 min read
Trustpilot